Kroger Co. stock slips as cyclosporiasis outbreak and lower sales guidance weigh on sentiment

Kroger Co. stock trades around USD 61.00 as of September 17, 2026 after the grocer cut its fiscal 2026 identical-sales forecast to 0.2% to 0.8%.

Cases and health response

Second-quarter fiscal 2026 sales still rose 2% year over year to USD 34.6 billion.

Kroger Co. stock (ISIN US5010441013) is trading around USD 61.00 on the New York Stock Exchange as of September 17, 2026, following a cut to the company’s fiscal 2026 identical-sales guidance after a costly cyclosporiasis outbreak linked to iceberg lettuce.

On September 17, 2026, The Kroger Co. disclosed that a summer outbreak of cyclosporiasis tied to iceberg lettuce caused more than USD 100 million in lost sales and reduced identical-store sales by about 0.35 percentage points in fiscal second quarter 2026, prompting a reduction in its full-year identical-sales forecast to a range of 0.2% to 0.8% growth from a prior 1% to 2%.

According to GuruFocus on September 17, 2026, the outbreak has become a central risk factor for the grocer’s near-term sales trajectory.